Cargando…

Presepsin as a Predictive Biomarker of Severity in COVID-19: A Systematic Review

BACKGROUND: The aim of this review is to evaluate the global scientific literature on the utility of plasma presepsin (PSP) as a prognostic biomarker in a homogeneous group of coronavirus disease 2019 (COVID-19) positive cases. DATA RETRIEVAL: A systematic review utilizing Medline (PubMed interface)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ahmed, Sibtain, Mansoor, Maheen, Shaikh, Muhammad S, Siddiqui, Imran
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Jaypee Brothers Medical Publishers 2021
Materias:	Systematic Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8664043/ https://www.ncbi.nlm.nih.gov/pubmed/34963726 http://dx.doi.org/10.5005/jp-journals-10071-23967

Ejemplares similares

Evaluation of serum ferritin for prediction of severity and mortality in COVID-19- A cross sectional study
por: Ahmed, Sibtain, et al.
Publicado: (2021)

Presepsin as a diagnostic and prognostic biomarker of severe bacterial infections and COVID-19
por: Kyriazopoulou, Evdoxia, et al.
Publicado: (2023)

Presepsin levels and COVID-19 severity: a systematic review and meta-analysis
por: Guarino, Matteo, et al.
Publicado: (2022)

Presepsin as a Novel Biomarker in predicting In‐hospital Mortality in Patients With COVID‐19 Pneumonia
por: Assal, Hebatallah Hany, et al.
Publicado: (2022)

PRESEPSIN AND MONOCYTE DISTRIBUTION WIDTH AS A USEFUL EARLY BIOMARKER OF SEVERITY IN PATIENTS WITH COVID-19
por: WON KIM, SEI
Publicado: (2021)

Presepsin Predicts Severity and Secondary Bacterial Infection in COVID-19 by Bioinformatics Analysis
por: Chang, Yufei, et al.
Publicado: (2022)

Prognostic Value of Serum Procalcitonin in COVID-19 Patients: A Systematic Review
por: Ahmed, Sibtain, et al.
Publicado: (2021)

Presepsin: A Promising Biomarker for Sepsis
por: Azim, Afzal
Publicado: (2021)

Presepsin as a Diagnostic and Prognostic Biomarker in Sepsis
por: Velissaris, Dimitrios, et al.
Publicado: (2021)

Impact of COVID-19 on laboratory professionals-A descriptive cross sectional survey at a clinical chemistry laboratory in a developing country
por: Jafri, Lena, et al.
Publicado: (2020)

Utility of Presepsin and Interferon-λ3 for Predicting Disease Severity and Clinical Outcomes in COVID-19 Patients
por: Lee, Gun-Hyuk, et al.
Publicado: (2023)

Serum stratifin and presepsin as candidate biomarkers for early detection of COVID-19 disease progression
por: Arakawa, Noriaki, et al.
Publicado: (2022)

Predictive value of presepsin and acylcarnitines for severity and biliary drainage in acute cholangitis
por: Zhang, Han-Yu, et al.
Publicado: (2023)

Ups and Downs of COVID-19: Can We Predict the Future? Local Analysis with Google Trends for Forecasting the Burden of COVID-19 in Pakistan
por: Ahmed, Sibtain, et al.
Publicado: (2021)

Is There a Role of Presepsin as a Novel Biomarker in Pediatric Sepsis?
por: Khera, Daisy, et al.
Publicado: (2022)

The role of C-reactive protein in predicting the severity of COVID-19 disease: A systematic review
por: Yitbarek, Getachew Yideg, et al.
Publicado: (2021)

Usefulness of monocyte distribution width and presepsin for early assessment of disease severity in COVID-19 patients
por: Kim, Sei Won, et al.
Publicado: (2022)

Characterizing the kinetics of presepsin and associated inflammatory biomarkers in human endotoxemia
por: Aulin, Linda B. S., et al.
Publicado: (2022)

Predictors of COVID-19 severity: a systematic review and meta-analysis
por: Mudatsir, Mudatsir, et al.
Publicado: (2021)

Increased presepsin levels are associated with the severity of fungal bloodstream infections
por: Bamba, Yuuki, et al.
Publicado: (2018)

The Use of Proton Pump Inhibitors and COVID-19: A Systematic Review and Meta-Analysis
por: Fatima, Kaneez, et al.
Publicado: (2022)

Presepsin: A potential biomarker of PJI? A comparative analysis with known and new infection biomarkers
por: Marazzi, Monica Gioia, et al.
Publicado: (2017)

Presepsin teardown - pitfalls of biomarkers in the diagnosis and prognosis of bacterial infection in cirrhosis
por: Papp, Maria, et al.
Publicado: (2016)

Presepsin as a promising biomarker for early detection of post-operative infection in children
por: Puspaningtyas, Niken Wahyu, et al.
Publicado: (2023)

Increased inflammatory markers correlate with liver damage and predict severe COVID-19: a systematic review and meta-analysis
por: Amiri-Dashatan, Nasrin, et al.
Publicado: (2020)

Encephalitis following COVID-19 Vaccination: A Systematic Review
por: Abdelhady, Mariam, et al.
Publicado: (2023)

Rash morphology as a predictor of COVID‐19 severity: A systematic review of the cutaneous manifestations of COVID‐19
por: Holmes, Zack, et al.
Publicado: (2022)

Accuracy of Presepsin in Sepsis Diagnosis: A Systematic Review and Meta-Analysis
por: Wu, Jiayuan, et al.
Publicado: (2015)

Diagnostic Value of Presepsin for Sepsis: A Systematic Review and Meta-Analysis
por: Zhang, Jing, et al.
Publicado: (2015)

Liver chemistries in severe or non-severe cases of COVID-19: A systematic review and meta-analysis
por: Dong, Xuan, et al.
Publicado: (2022)

Ability of presepsin concentrations to predict mortality in adult patients with sepsis
por: Aliu-Bejta, Ajete, et al.
Publicado: (2023)

Validation of presepsin measurement for mortality prediction of sepsis: a preliminary study
por: Baik, Seung Min, et al.
Publicado: (2022)

Severity of COVID-19 in Patients with Diarrhoea: A Systematic Review and Meta-Analysis
por: Dhakal, Sunita, et al.
Publicado: (2023)

Challenges amid COVID-19 times - Review of the changing practices in a clinical chemistry laboratory from a developing country
por: Ahmed, Sibtain, et al.
Publicado: (2020)

Daily combined measurement of platelet count and presepsin concentration can predict in-hospital death of patients with severe coronavirus disease 2019 (COVID-19)
por: Ishikura, Hiroyasu, et al.
Publicado: (2023)

Is COVID-19 impacting cancer screening in Pakistan? An observational study of cancer screening test requests during the pandemic
por: Ahmed, Dr Sibtain, et al.
Publicado: (2021)

Effect of Intravenous IgM-Enriched Immunoglobulins on Presepsin and Other Sepsis Biomarkers
por: Scarpati, Giuliana, et al.
Publicado: (2021)

Presepsin: Hope in the Quest for the Holy Grail
por: Samprathi, Abhishek, et al.
Publicado: (2022)

Cystatin C, COVID-19 severity and mortality: a systematic review and meta-analysis
por: Zinellu, Angelo, et al.
Publicado: (2021)

Prognostic Utility of Procalcitonin, Presepsin, and the VACO Index for Predicting 30-day Mortality in Hospitalized COVID-19 Patients
por: Park, Mikyoung, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_80t2538ib7trv9k5h7r98gf6h5